Clinical Trial Update: A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers [Phase 4]

View source ↗

Summary

This Phase IV, open-label, cross-over study evaluated potential drug interaction between lamivudine and sorbitol oral solution in healthy volunteers; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• Sorbitol oral solution (sorbitol)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED | Results posted: 2017-05-15